European Environmentally Related Tax Revenue from All Environmental Taxes in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Million US Dollars PPP = 2015)

In 2023, Italy led the European environmentally related tax revenue in the manufacturing sector of pharmaceuticals, reaching 24.74 million US dollars PPP, marking a 1.2% increase from the previous year. Conversely, Poland saw a slight decline of 0.17%, settling at 16.99 million US dollars PPP. Switzerland, the UK, and the Netherlands experienced notable increases, with variations of 2.39%, 2.78%, and 2.28% respectively. Norway topped the growth chart with an 8.94% rise, despite its relatively low tax revenue base. On the downside, Bulgaria faced a substantial decline of 31.56% in its revenue.

Looking forward, the trajectory of environmentally related tax revenue within the European pharmaceutical manufacturing sector will likely continue to evolve. Key trends include the increasing adoption of green technologies and sustainability practices, which are expected to influence tax adjustments. Policies promoting environmentally friendly innovations will play a critical role. Monitoring country-specific regulatory changes will provide insights into potential shifts in this revenue stream.